Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ProPharma Uppsala AB
AB
Active
Org 5568548522
Nohabgatan 14, 461 29
Trollhättan
Computer consultancy and computer facilities management activities
· NACE 6220
Est. 2011
1 employees
Watchlist
Share
Sweden
/
Companies
/
Computer consultancy and computer facilities management activities
/
ProPharma Uppsala AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
1M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
302
1 247
2 001
2 052
2 149
Staff expenses
—
−549
−1 151
−1 229
−1 237
EBITDA
123
467
605
593
668
Depreciation & amort.
−12
−7
−7
−7
—
EBIT
111
461
598
587
668
Net financials
25
−14
9
16
−12
Profit before tax
136
446
607
602
656
Tax
−28
−94
−125
−123
−139
Net profit
108
352
482
479
517
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
204
602
857
1 053
981
Equity
158
405
547
561
613
Long-term debt
0
—
—
—
—
Short-term debt
47
197
310
492
367
Total debt
47
197
310
492
367
Financial ratios
5-year trend
EBITDA margin
31.1%
This company
15.8%
Market median
+97% vs market
2021
2025
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
2021
2025
Return on equity
84.3%
This company
18.4%
Market median
+358% vs market
2021
2025
Net profit margin
24.1%
This company
8.1%
Market median
+198% vs market
2021
2025
Asset turnover
2.19×
This company
1.12×
Market median
+96% vs market
2021
2025
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on ProPharma Uppsala AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network